Conducting Studies with a Marketed ...

Conducting Studies with a Marketed Compound--A delicate balance

In 2001 the pharmaceutical and biotech industries added 32 modern treatments to the disease-fighting armamentarium. (1) further that's hardly the [i]finale[/i] of the story.

Now that the recent products are launched, ongoing Phase 4 registries and observational and postmarketing trials will be initiated to continue collecting information forward safety, physician usage, and patient satisfaction. These trials show to be an altogether different challenge as the returns enters the marketplace. As companies continue to guard studies ...